Menu
  • Join
  • Login
  • Contact
 

Search abstracts


COMMUNICATING EVIDENCE TO PRESCRIBERS AND PUBLIC ON SAFE USE OF ANTIHISTAMINES AND DECONGESTANTS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: NAWAZ, Hafiz Awais (University of Veterinary & Animal Sciences (UVAS), Institute of Pharmaceutical Sciences (IPS), Pakistan)
  • Co-author(s): Asma Nadeem: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
    Hafiza Mahnoor Basharat: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
    Alweena Habib: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
    Areeba Ali: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
    Tehreem Akram : Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
    Hafiz Awais Nawaz: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
    Huma Rasheed: Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS), Lahore, Pakistan
  • Abstract:

    Background

    Evidence-based practice (EBP) can contribute to improve health system practices. Lack of communication to the public and prescribers is among the main challenges and leads to irrational therapy. E.g., an excess of cough and cold medications (antihistamines and decongestants) are used in acute respiratory tract infections by prescribers..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses